Emergent BioSolutions ‘hopeful’ to return to vaccine production, plans to respond to FDA ‘within days’ – Washington Business Journal

By Super UserMay 3, 2021News

Home » Emergent BioSolutions ‘hopeful’ to return to vaccine production, plans to respond to FDA ‘within days’ – Washington Business Journal

On a first-quarter earnings call Thursday, Emergent’s CEO addressed a turbulent month for the Gaithersburg biopharmaceutical company.

Image: https://www.bizjournals.com

{iframe}https://www.bizjournals.com/washington/news/2021/04/29/emergent-biosolutions-to-submit-response-to-fda.html{/iframe}